A celebration of progress toward a cure for diabetes
With entertainment by three-time Grammy-Award-winning vocal group PENTATONIX
MONDAY, OCTOBER 16, 2017
National Cowboy & Western Heritage Museum, Oklahoma City, OK
Benefiting Harold Hamm Diabetes Center at the University of Oklahoma
Emcee: NICOLE JOHNSON, Miss America 1999 and Diabetes Expert/Advocate | More about Nicole
5:30pm VIP Reception | 6:30 General Reception | 7:00 Dinner Program
Explore Sponsorship Opportunities for Connect+Cure 2017
CLICK HERE FOR PHOTOS FROM THE 2015 EVENT
Diabetes is a recent epidemic. We know when and how it started. Now we need your help to end it.
One in three Americans will develop diabetes during their lifetime. One in three Oklahomans already has diabetes or prediabetes. The crisis is here, and it can’t wait any longer. Scientific knowledge and skill are only part of the answer. When we finally defeat the diabetes epidemic, it will be because people like you cared, acted, and gave.
Connect+Cure is a biennial gala event to benefit Harold Hamm Diabetes Center, but it’s also much more than that. It’s an awareness-generator and consensus-builder that explains why diabetes needs to be a national priority. It’s a showcase for our center here in Oklahoma and the work we do every day.
Just as importantly, Connect+Cure is where we celebrate the achievements that bring us closer every day to our ultimate goal. On this night, we’ll honor the 2017 laureate of the Harold Hamm International Prize for Biomedical Research in Diabetes – a scientist whose advances have forever changed the way diabetes is treated, understood and/or prevented. The Hamm Prize is the largest prize for diabetes research in the world. View the news release about 2017 Prize Laureate Dr. Ralph DeFronzo
Finally, Connect+Cure is a party with plenty of entertainment value. Past special guests at Connect+Cure include Dr. Oz, Ben Vereen, Alison Krauss, Harry Smith, and Toby Keith.
Can’t join our big event this year? We understand and will miss you. But won’t you consider one or more of the following?